Source: Eur Respir J, 56 (4) 2002554; 10.1183/13993003.02554-2020
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Darius Armstrong-James, Jonathan Youngs, Tihana Bicanic, Alireza Abdolrasouli, David W. Denning, Elizabeth Johnson, Varun Mehra, Tony Pagliuca, Brijesh Patel, Johanna Rhodes, Silke Schelenz, Anand Shah, Frank L. van de Veerdonk, Paul E. Verweij, P. Lewis White, Matthew C. Fisher. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Respir J, 56 (4) 2002554; 10.1183/13993003.02554-2020

Member's Comments

No comment yet.

Related content which might interest you: Predicting risk of mortality of chronic pulmonary aspergillosis Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections Year: 2020 Predictors of mortality in chronic pulmonary aspergillosis Source: Eur Respir J , 49 (2) 1601062; DOI: 10.1183/13993003.01062-2016 Year: 2017 Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021 Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis Source: Eur Respir J , 49 (2) 1602520; DOI: 10.1183/13993003.02520-2016 Year: 2017 PET‘s importance in chronic pulmonary aspergillosis Source: Eur Respir J 2006; 28: Suppl. 50, 560s Year: 2006 Chronic sinusitis may be one of the risk factors developing and deteriorating primary MAC pulmonary disease in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 414s Year: 2005 Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Comparison of risk assessment strategies for not-high-risk pulmonary embolism Source: Eur Respir J 2016; 47: 1170-1178 Year: 2016 Pulmonary aspergillosis: a clinical review Source: Eur Respir Rev 2011; 20: 156-174 Year: 2011 Pulmonary nocardiosis in immunocompetent patients: can COPD be the only risk factor? Source: Eur Respir Rev 2011; 20: 210-212 Year: 2011 Determinants and assessment of excess cardiovascular risk in bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Allergic bronchopulmonary aspergillosis as an occupational disease - special risk in waste management Source: International Congress 2017 – Case reports and series Year: 2017 The development of pulmonary hypertension after first episode of acute pulmonary embolism and related risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Severe pulmonary sarcoidosis: definition and risk stratification Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Risk assessment in severe pulmonary hypertension due to interstitial lung disease Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Increased incidence of pulmonary embolism in severe asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011